| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 3784735
[patent_doc_number] => 05736361
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-04-07
[patent_title] => 'Production of gonorrheal PI proteins'
[patent_app_type] => 1
[patent_app_number] => 7/983995
[patent_app_country] => US
[patent_app_date] => 1992-12-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 13
[patent_no_of_words] => 13738
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/736/05736361.pdf
[firstpage_image] =>[orig_patent_app_number] => 983995
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/983995 | Production of gonorrheal PI proteins | Nov 30, 1992 | Issued |
| 07/972355 | HUMAN PAPILLOMAVIRUS TYPE 52 DNA SEQUENCES AND METHODS FOR EMPLOYING THE SAME | Nov 4, 1992 | Abandoned |
Array
(
[id] => 3411707
[patent_doc_number] => 05443969
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1995-08-22
[patent_title] => 'RNA packaging system'
[patent_app_type] => 1
[patent_app_number] => 7/971101
[patent_app_country] => US
[patent_app_date] => 1992-10-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 15
[patent_no_of_words] => 10975
[patent_no_of_claims] => 68
[patent_no_of_ind_claims] => 15
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/443/05443969.pdf
[firstpage_image] =>[orig_patent_app_number] => 971101
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/971101 | RNA packaging system | Oct 28, 1992 | Issued |
Array
(
[id] => 3504598
[patent_doc_number] => 05514586
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1996-05-07
[patent_title] => 'Plasmid vectors and GRAS microorganisms promoting ice nucleation'
[patent_app_type] => 1
[patent_app_number] => 7/963290
[patent_app_country] => US
[patent_app_date] => 1992-10-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 40
[patent_no_of_words] => 12622
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 5
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/514/05514586.pdf
[firstpage_image] =>[orig_patent_app_number] => 963290
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/963290 | Plasmid vectors and GRAS microorganisms promoting ice nucleation | Oct 18, 1992 | Issued |
| 07/959010 | TAENIA ANTIGENS FOR USE AS IMMUNODIAGNOSTIC REAGENTS FOR BOVINE OR SWINE CYSTICERCOSIS | Oct 8, 1992 | Abandoned |
Array
(
[id] => 3061029
[patent_doc_number] => 05310661
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1994-05-10
[patent_title] => 'Nucleic acid encoding the .alpha. chain prodomains of inhibin and method for synthesizing polypeptides using such nucleic acid'
[patent_app_type] => 1
[patent_app_number] => 7/958414
[patent_app_country] => US
[patent_app_date] => 1992-10-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 24
[patent_no_of_words] => 17072
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/310/05310661.pdf
[firstpage_image] =>[orig_patent_app_number] => 958414
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/958414 | Nucleic acid encoding the .alpha. chain prodomains of inhibin and method for synthesizing polypeptides using such nucleic acid | Oct 7, 1992 | Issued |
| 07/953772 | VECTOR FOR INTEGRATION SITE INDEPENDENT GENE EXPRESSION IN MAMMALIAN HOST CELLS | Sep 29, 1992 | Abandoned |
| 07/948472 | TRANSLATION OF MRNA | Sep 21, 1992 | Abandoned |
Array
(
[id] => 3678698
[patent_doc_number] => 05632989
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-05-27
[patent_title] => 'Attenuated, live vaccine for Delaware strain IBDV'
[patent_app_type] => 1
[patent_app_number] => 7/944525
[patent_app_country] => US
[patent_app_date] => 1992-09-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 2590
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/632/05632989.pdf
[firstpage_image] =>[orig_patent_app_number] => 944525
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/944525 | Attenuated, live vaccine for Delaware strain IBDV | Sep 14, 1992 | Issued |
| 07/941371 | SELF-ASSEMBLING RECOMBINANT PAPILLOMAVIRUS CAPSID PROTEINS | Sep 2, 1992 | Abandoned |
Array
(
[id] => 3485215
[patent_doc_number] => 05425946
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1995-06-20
[patent_title] => 'Vaccines against group C Neisseria meningitidis'
[patent_app_type] => 1
[patent_app_number] => 7/938367
[patent_app_country] => US
[patent_app_date] => 1992-08-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4842
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 54
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/425/05425946.pdf
[firstpage_image] =>[orig_patent_app_number] => 938367
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/938367 | Vaccines against group C Neisseria meningitidis | Aug 30, 1992 | Issued |
| 07/938100 | FUSION GLYCOPROTEINS | Aug 27, 1992 | Abandoned |
Array
(
[id] => 4061658
[patent_doc_number] => 05866383
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-02-02
[patent_title] => 'In vitro ligation of foreign DNA into large eukaryotic viruses'
[patent_app_type] => 1
[patent_app_number] => 7/935812
[patent_app_country] => US
[patent_app_date] => 1992-08-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 8
[patent_no_of_words] => 11238
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/866/05866383.pdf
[firstpage_image] =>[orig_patent_app_number] => 935812
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/935812 | In vitro ligation of foreign DNA into large eukaryotic viruses | Aug 25, 1992 | Issued |
Array
(
[id] => 4061658
[patent_doc_number] => 05866383
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-02-02
[patent_title] => 'In vitro ligation of foreign DNA into large eukaryotic viruses'
[patent_app_type] => 1
[patent_app_number] => 7/935812
[patent_app_country] => US
[patent_app_date] => 1992-08-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 8
[patent_no_of_words] => 11238
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/866/05866383.pdf
[firstpage_image] =>[orig_patent_app_number] => 935812
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/935812 | In vitro ligation of foreign DNA into large eukaryotic viruses | Aug 25, 1992 | Issued |
| 07/932334 | NOVEL PROMOTERS FROM CHLORELLA VIRUS GENES PROVIDING FOR EXPRESSION OF GENES IN PROKARYOTIC AND EUKARYOTIC HOSTS | Aug 18, 1992 | Abandoned |
| 07/925061 | RECOMBINANT NEGATIVE STRAND RNA VIRUS EXPRESSION SYSTEMS AND VACCINES | Aug 3, 1992 | Abandoned |
| 07/925820 | LIVE VACCINE AGAINST COLIBACILLOSIS | Aug 3, 1992 | Abandoned |
Array
(
[id] => 3646850
[patent_doc_number] => 05605692
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-02-25
[patent_title] => 'Expression of structural (P1) region of 1 hepatitis A virus by vaccinia in cell culture for use in vaccines'
[patent_app_type] => 1
[patent_app_number] => 7/916149
[patent_app_country] => US
[patent_app_date] => 1992-07-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 5
[patent_no_of_words] => 3010
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/605/05605692.pdf
[firstpage_image] =>[orig_patent_app_number] => 916149
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/916149 | Expression of structural (P1) region of 1 hepatitis A virus by vaccinia in cell culture for use in vaccines | Jul 30, 1992 | Issued |
Array
(
[id] => 3092846
[patent_doc_number] => 05369026
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1994-11-29
[patent_title] => 'DNA encoding bovine coronavirus polypeptides E2 and E3'
[patent_app_type] => 1
[patent_app_number] => 7/919976
[patent_app_country] => US
[patent_app_date] => 1992-07-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 34
[patent_figures_cnt] => 14
[patent_no_of_words] => 10841
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/369/05369026.pdf
[firstpage_image] =>[orig_patent_app_number] => 919976
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/919976 | DNA encoding bovine coronavirus polypeptides E2 and E3 | Jul 26, 1992 | Issued |
Array
(
[id] => 3585744
[patent_doc_number] => 05585103
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1996-12-17
[patent_title] => 'Induction of cytotoxic T-lymphocyte responses'
[patent_app_type] => 1
[patent_app_number] => 7/919787
[patent_app_country] => US
[patent_app_date] => 1992-07-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 14
[patent_no_of_words] => 9638
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 122
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/585/05585103.pdf
[firstpage_image] =>[orig_patent_app_number] => 919787
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/919787 | Induction of cytotoxic T-lymphocyte responses | Jul 23, 1992 | Issued |